Company:  MOMENTA PHARMACEUTICALS I ... (MNTA)
Form Type:  S-1/A
Filing Date:  6/15/2004 
CIK:  0001235010 
Address:  675 WEST KENDALL STREET 
City, State, Zip:  CAMBRIDGE, Massachusetts 02142 
Telephone:  617 491-9700 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$13.26   		Change: 
0.18 (1.38%)  
Trade Time: 
04:00 PM EST   		Market Cap: 
$688.53M
Description of Business
Register for a Free Trial and access this filing in:     
  FORM S-1/A
    CIBC World Markets ThinkEquity Partners LLC
    TABLE OF CONTENTS
    SUMMARY
    THE OFFERING
    SUMMARY FINANCIAL AND OPERATING DATA
    RISK FACTORS
    SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION
    USE OF PROCEEDS
    DIVIDEND POLICY
    CAPITALIZATION
    DILUTION
      BENEFICIAL OWNERS
    SELECTED FINANCIAL AND OPERATING DATA
    MANAGEMENT'S DISCUSSION AND ANALYSIS OF
      Liquidity and Capital Resources
    BUSINESS
      Competition
    Regulatory and Legal Matters
      Employees
      Legal Proceedings
    MANAGEMENT
      NAME AND TITLE
    Director Compensation
      Compensation Committee Interlocks and Insider Participation
    Executive Compensation
      COMPENSATION TABLE
      OPTIONS
      OPTIONS AGGREGATE
        Stock Option and Other Compensation Plans
    CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
      BENEFICIAL OWNERS
      BENEFICIAL OWNERS
      BENEFICIAL OWNERS
      BENEFICIAL OWNERS
      BENEFICIAL OWNERS
    PRINCIPAL STOCKHOLDERS
      BENEFICIAL OWNERS
      BENEFICIAL OWNERS
    DESCRIPTION OF CAPITAL STOCK
    Transfer Agent and Registrar
    SHARES ELIGIBLE FOR FUTURE SALE
    UNDERWRITING
      Indemnification
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
    INDEX TO FINANCIAL STATEMENTS
      REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
      BALANCE SHEET
      INCOME STATEMENT
      STOCKHOLDERS EQUITY
      STOCKHOLDERS EQUITY
      CASH FLOW
      NOTES TO FINANCIAL STATEMENTS
    PART II
      Item 13. Other Expenses of Issuance and Distribution.
      Item 14. Indemnification of Directors and Officers.
      Item 15. Recent Sales of Unregistered Securities.
      Item 16. Exhibits and Financial Statement Schedules.
      Item 17. Undertakings.
    SIGNATURES
    SIGNATURES AND POWER OF ATTORNEY
    EXHIBIT INDEX
  EXHIBIT 1.1
  EXHIBIT 4.1
  EXHIBIT 4.3
  EXHIBIT 5.1
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT AUDITORS
© 1995-2013 EDGAR Online, Inc. All rights reserved • NASDAQ: EDGR • Solutions for Corporations • Terms of Use • Privacy Statement